High Quality Azilsartan CAS NO.147403-03-0
- FOB Price: USD: 1.00-1.00 /Gram Get Latest Price
- Min.Order: 1 Gram
- Payment Terms: L/C,D/A,D/P,T/T,
- Available Specifications:
1(1-2)Gram
- Product Details
Keywords
- 147403-03-0
- Azilsartan
- Azilsartan Price
Quick Details
- ProName: High Quality Azilsartan
- CasNo: 147403-03-0
- Molecular Formula: C25H20N4O5
- Appearance: White powder
- Application: pharmaceutical intermediates
- DeliveryTime: Qingdao Port
- PackAge: 1kg or 25Kg drum
- Port: QIngdao Port
- ProductionCapacity: 3000 Metric Ton/Year
- Purity: 98% HPLC
- Storage: Store in dry, dark and ventilated plac...
- Transportation: By air or by sea. Prompt delivery
- LimitNum: 1 Gram
- Moisture Content: See data sheet
- Samples: Available
Superiority
We promise our customer following items
1.Reasonable price:
2.Low moq:No worry about the low moq, our moq is 1 gram or lower.
3.Good and efficient service,Fast Delivery
4.Super-good quality
Contact us
If you have any further questions or need a sample,Please do not hesitate to contact us.
Jessica | Senior Sales | Qingdao Sigma chemical Co.,Ltd
| Address:No 70,Shandong Road,Qingdao city,China
Details
147403-03-0
Azilsartan
Trade Names | Edarbi® |
Synonyms |
2-ethoxy-3-[[4-[2-(5-oxo-2H-1,2,4-oxadiazol-3-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylic acid; 1H-Benzimidazole-7-carboxylic acid,1-[[2'-(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-yl]methyl]-2-ethoxy; HP3049; TAK536 |
CAS | 147403-03-0 |
Assay |
NLT 99%
|
Introduction:
Edarbi (azilsartan medoxomil), a prodrug, is hydrolyzed to azilsartan in the gastrointestinal tract during absorption. Azilsartan is a selective AT1 subtype angiotensin II receptor antagonist. It's mechanism of action is to lower blood pressure by inhibiting action of vasopressor hormone Angiotensin II, a polypeptide that causes vasoconstriction, increased blood pressure and aldosterone release.
Edarbi is specifically indicated for the treatment of hypertension, alone or in combination with other antihypertensive agents.
Edarbi is supplied as a tablet for oral administration. The recommended initial dose in adults is 80 mg taken orally once daily.